2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists
Authors:
- 15 February 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (4) , 955-958
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulatorsBioorganic & Medicinal Chemistry Letters, 2007
- The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screeningBioorganic & Medicinal Chemistry Letters, 2007
- A bioisosteric approach to the discovery of indole carbinol androgen receptor ligandsBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulatorsBioorganic & Medicinal Chemistry Letters, 2006
- Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligandsBioorganic & Medicinal Chemistry Letters, 2006
- Nonsteroidal tissue selective androgen receptor modulators: a promising class of clinical candidatesExpert Opinion on Therapeutic Patents, 2005
- Chapter 17. Selective androgen receptor modulators (SARMs)2001
- Selective Androgen Receptor Modulators (SARMs): A Novel Approach to Androgen Therapy for the New MillenniumThe Journal of Clinical Endocrinology & Metabolism, 1999
- Discovery of Nonsteroidal AndrogensBiochemical and Biophysical Research Communications, 1998
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988